Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice

Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice
Promising data from Sangamo Therapeutics‘ research programs, including Alzheimer’s disease, were recently announced. The results were presented during the 20th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Washington, D.C. Sangamo’s work in Alzheimer’s revealed a significant reduction in the production of tau, a key protein in several neurodegenerative diseases when aggregated, using

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

Leave a Comment

Your email address will not be published. Required fields are marked *